安进公司 AMGN 深 沪
等待开盘 01-28 09:30:00 美东时间
352.23
+2.540
+0.73%
华盛通- 最 高353.25
- 今 开348.57
- 成交量 83.48万股
- 最 低 348.57
- 昨 收 349.69
- 总市值 1895.00亿
- 52周最高 353.25
- 市盈率 静 46.59
- 换手率 0.16%
- 52周最低 254.29
- 委 比 17.94%
- 总股本 5.38亿
- 历史最高 353.25
- 量 比 0.67
- 振 幅 1.34%
- 历史最低 -25.919
- 每 手 1
- 风险率 21.64%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 斯伦贝谢、SouthState Bank、西屋制动、特里科银行获多家大行上调目标价；苹果、meta、微软等绩前遭下调目标价
今日重点评级关注：Oppenheimer：维持Pelthos Therapeutics"跑赢大市"评级，目标价从57美元升至60美元；Small Cap Consumer Research：维持Lands' End"买入"评级，目标价从20美元升至45美元
01-27 10:02
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions Pharmaceutical companies describe AI benefits for tedious work Novartis says AI cut trial site selection from weeks to a two-hour meeting Drugmakers use AI to draft regulator-ready filings By Maggie Fick and Michael Erman SAN FRANCI
01-26 19:00
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies
U.S. RESEARCH ROUNDUP-CACI International, First Citizens Bancshares, Teledyne Technologies Jan 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including CACI International, First Citizens Bancshares and Teledyne Technologies, o
01-26 15:22
Peering Into Amgen Inc's Recent Short Interest
Amgen Inc's (NYSE:AMGN) short interest as a percent of float has risen 6.08% si...
01-24 03:00
SA analyst upgrades/downgrades: GE, MSFT, SMCI, AMGN
GE Aerospace (GE) receives a rating upgrade from Dhierin Bechai, who argues that valuation concerns based on P/E ratios are misleading, while Amgen (AMGN) earns a Buy rating from Edmund Ingham on the ...
01-23 23:36
MBX Biosciences Appoints Laurie Stelzer to Board of Directors as Audit Committee Chair
MBX Biosciences has appointed Laurie Stelzer as an independent director and chair of the audit committee, leveraging her extensive financial and executive experience. Stelzer, with a strong background in biopharmaceutical finance, is expected to contribute to the company’s upcoming clinical data releases and Phase 3 trial in hypoparathyroidism. MBX Biosciences focuses on developing precision peptide therapies for endocrine and metabolic disorders...
01-22 13:00
Amgen downgraded at Bernstein on 2026 outlook
Bernstein has downgraded Amgen (AMGN) to Market Perform from Outperform, arguing that 2026 could be a “waiting year” for the pharma giant and its stock will remain within 15% of its $335 per share tar...
01-21 23:18
美股大行评级 | 存储再获大行看好！花旗、瑞银和美银齐上调西部数据、希捷科技等公司目标价；PNC金融服务获6家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Soleno Therapeutics"买入"评级，目标价从110美元升至120美元；富国银行：维持Soleno Therapeutics"超配"评级，目标价从106美元升至114美元
01-21 11:42
Bernstein Downgrades Amgen to Market Perform, Maintains Price Target to $335
Bernstein analyst Courtney Breen downgrades Amgen (NASDAQ:AMGN) from Outperform to Market Perform and maintains the price target from $335 to $335.
01-21 00:12
Amgen Reports MariTide Weight Loss Holds Up With Fewer Doses
Amgen says its MariTide obesity drug helped patients maintain weight loss for a second year, with good safety and fewer side effects.
01-15 01:36
